UNSPSC 51151650: Methantheline

This classification denotes an antimuscarinic agent with the molecular formula C21H26NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36EI79TX7I, chemically known as xanthene-9-carboxylic acid, ester with diethyl(2-hydroxyethyl)methylammonium bromide but generally known as methantheline, which bears US NIH Compound Identifier 4097. World Health Organization schedules methantheline in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, METHANTHELINE remains the US FDA Preferred Term for this commodity.

Methantheline bears US NLM identifiers UMLS ID C0025624 and NCI Concept Code C83951. SMILES: CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13..

UNSPSC 51151650 Methantheline is a Commodity code that in practice captures pharmaceutical and drug-related products procured by state and local health agencies, though the recent solicitation record shows a significant mismatch between the code's nominal scope and what is actually being tagged under it. Seminole County, Florida recently posted an IFB for Naloxone and Safe Drug Deactivation Systems — community health supplies — under this code, indicating that state and local procurement databases may apply pharmaceutical codes broadly to health-related drug or medical products rather than strictly to the chemical compound named in the code definition. The work solicited under the code in recent activity centers on the acquisition and distribution of pharmaceutical and harm-reduction supplies to support public health initiatives, with vendors responsible for delivery logistics and quarterly or recurring shipment schedules.

The issuing bodies active under this code include county health departments and community health agencies. Seminole County, Florida represents the most visible recent activity. The geographic spread in the available record is limited to Florida. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023; vendors must submit bids electronically through the county's e-Procurement Portal, include all shipping and delivery costs in their proposal, hold drug-free workplace certification and E-Verify compliance, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract carries a two-year initial term with an optional one-year renewal and includes a three-month probationary termination clause. No explicit set-aside or disadvantaged-enterprise designation was stated in the solicitation.